Literature DB >> 24985124

Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.

Olga Tsiatsiou1, Εlias Iosifidis, Aspasia Katragkou, Vasiliki Dimou, Kosmas Sarafidis, Theodoros Karampatakis, Charalampos Antachopoulos, Anagnostina Orfanou, Athanasios Tsakris, Vasiliki Drossou-Agakidou, Emmanuel Roilides.   

Abstract

UNLABELLED: The investigation and successful management of a monoclonal Acinetobacter baumannii outbreak in a neonatal intensive care unit are described. Upon the first clustered carbapenem-resistant A. baumannii (CRAB) infections, a bundle of actions were taken, including enhanced infection control, active surveillance (weekly stool samples), case-control study, staff education, daily audits and discontinuation of new admissions. Between September and December 2011, eight neonates developed 10 CRAB infections (five blood, four respiratory and one eye). A total of 216 active surveillance cultures were obtained from 96 neonates (43 % had ≥2 samples). During weeks 12, 16 and 17, active surveillance detected 3, 1 and 2 new CRAB acquisitions, respectively. Prevalence of infections/colonizations decreased, and no event occurred after 20th week. A colonized neonate developed CRAB sepsis and died. All CRAB isolates harboured bla OXA-58 and the intrinsic chromosomal bla OXA-51 carbapenemase genes.
CONCLUSION: Active surveillance and enhanced infection control measures effectively contained spread of CRAB clone in the neonatal intensive care unit.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24985124     DOI: 10.1007/s00431-014-2365-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  Serum and cerebrospinal fluid levels of colistin in pediatric patients.

Authors:  Charalampos Antachopoulos; Matti Karvanen; Elias Iosifidis; Britt Jansson; Diamantis Plachouras; Otto Cars; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

2.  Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  Glenn A Pankuch; Gengrong Lin; Harald Seifert; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

Review 3.  Use of colistin in children.

Authors:  Pranita D Tamma; Carlton K Lee
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

4.  Control of an Acinetobacter [corrected] baumannii outbreak in a neonatal ICU without suspension of service: a devastating outbreak in Diyarbakir, Turkey.

Authors:  S Hosoglu; M Hascuhadar; E Yasar; S Uslu; B Aldudak
Journal:  Infection       Date:  2011-09-01       Impact factor: 3.553

5.  Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece.

Authors:  Helena C Maltezou; Flora Kontopidou; Xanthi Dedoukou; Panagiotis Katerelos; Georgios-Michael Gourgoulis; Paraskeui Tsonou; Antonis Maragos; Panagiotis Gargalianos; Achilleas Gikas; Charalambos Gogos; Ioannis Koumis; Moyssis Lelekis; Efstratios Maltezos; Georgia Margariti; Pavlos Nikolaidis; Angelos Pefanis; George Petrikkos; George Syrogiannopoulos; Athanassios Tsakris; Alkiviadis Vatopoulos; George Saroglou; Jenny Kremastinou; George L Daikos
Journal:  J Glob Antimicrob Resist       Date:  2013-08-13       Impact factor: 4.035

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 7.  OXA (beta)-lactamases in Acinetobacter: the story so far.

Authors:  Susan Brown; Sebastian Amyes
Journal:  J Antimicrob Chemother       Date:  2005-12-06       Impact factor: 5.790

8.  Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine.

Authors:  Abdel Moati Kh Al Jarousha; Abdel Hakeem N El Jadba; Ahmed S Al Afifi; Iyad A El Qouqa
Journal:  Int J Infect Dis       Date:  2009-01-13       Impact factor: 3.623

9.  Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit.

Authors:  R Melamed; D Greenberg; N Porat; M Karplus; E Zmora; A Golan; P Yagupsky; R Dagan
Journal:  J Hosp Infect       Date:  2003-01       Impact factor: 3.926

10.  Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.

Authors:  Matthew E Falagas; Georgia Sideri; Evridiki K Vouloumanou; John H Papadatos; Dimitris A Kafetzis
Journal:  Pediatr Infect Dis J       Date:  2009-02       Impact factor: 2.129

View more
  11 in total

1.  Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit.

Authors:  Theodoros Karampatakis; Katerina Tsergouli; Lida Politi; Georgia Diamantopoulou; Elias Iosifidis; Charalampos Antachopoulos; Aggeliki Karyoti; Maria Sdougka; Athanassios Tsakris; Emmanuel Roilides
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

Review 2.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 3.  Outbreaks in the neonatal ICU: a review of the literature.

Authors:  Julia Johnson; Caroline Quach
Journal:  Curr Opin Infect Dis       Date:  2017-08       Impact factor: 4.915

Review 4.  Acinetobacter Infections in Neonates.

Authors:  Raffaele Zarrilli; Maria Bagattini; Eliana Pia Esposito; Maria Triassi
Journal:  Curr Infect Dis Rep       Date:  2018-10-10       Impact factor: 3.725

5.  Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.

Authors:  Yongxin Zhao; Kewang Hu; Jisheng Zhang; Yuhang Guo; Xuecai Fan; Yong Wang; Sedzro Divine Mensah; Xiaoli Zhang
Journal:  BMC Infect Dis       Date:  2019-05-22       Impact factor: 3.667

6.  Control of Acinetobacter baumannii outbreak in the neonatal intensive care unit in Latvia: whole-genome sequencing powered investigation and closure of the ward.

Authors:  A Gramatniece; I Silamikelis; Ie Zahare; V Urtans; Ir Zahare; E Dimina; M Saule; A Balode; I Radovica-Spalvina; J Klovins; D Fridmanis; U Dumpis
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-22       Impact factor: 4.887

7.  Molecular Epidemiology and Mechanisms of Carbapenem-Resistant Acinetobacter baumannii Isolates from ICU and Respiratory Department Patients of a Chinese University Hospital.

Authors:  Bin Liu; Lei Liu
Journal:  Infect Drug Resist       Date:  2021-02-25       Impact factor: 4.003

8.  Relationship Between COVID-19 Lockdown and Epidemiology of Neonatal Sepsis.

Authors:  Sourabh Dutta; Praveen Kumar; Rajarajan Paulpandian; Shiv Sajan Saini; Priya Sreenivasan; Kanya Mukhopadhyay; Venkataseshan Sundaram; Jogender Kumar; Pallab Ray
Journal:  Pediatr Infect Dis J       Date:  2022-05-06       Impact factor: 3.806

9.  Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Subhasree Roy; Vivek Junghare; Shanta Dutta; Saugata Hazra; Sulagna Basu
Journal:  mSystems       Date:  2022-06-23       Impact factor: 7.324

10.  Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Acinetobacter baumanii Blood Isolates in Indonesia: A Multicenter Study.

Authors:  Dewi Anggraini; Dewi Santosaningsih; Yulia Rosa Saharman; Pepy Dwi Endraswari; Cahyarini Cahyarini; Leli Saptawati; Zinatul Hayati; Helmia Farida; Cherry Siregar; Munawaroh Pasaribu; Heriyannis Homenta; Enty Tjoa; Novira Jasmin; Rosantia Sarassari; Wahyu Setyarini; Usman Hadi; Kuntaman Kuntaman
Journal:  Antibiotics (Basel)       Date:  2022-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.